Teladoc Stock Alpha and Beta Analysis
| TDOC Stock | USD 5.78 0.13 2.20% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Teladoc. It also helps investors analyze the systematic and unsystematic risks associated with investing in Teladoc over a specified time horizon. Remember, high Teladoc's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Teladoc's market risk premium analysis include:
Beta 2.17 | Alpha (0.63) | Risk 2.86 | Sharpe Ratio (0.21) | Expected Return (0.61) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Teladoc Backtesting, Teladoc Valuation, Teladoc Correlation, Teladoc Hype Analysis, Teladoc Volatility, Teladoc History and analyze Teladoc Performance. Teladoc Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Teladoc market risk premium is the additional return an investor will receive from holding Teladoc long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Teladoc. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Teladoc's performance over market.| α | -0.63 | β | 2.17 |
Teladoc expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Teladoc's Buy-and-hold return. Our buy-and-hold chart shows how Teladoc performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Teladoc Market Price Analysis
Market price analysis indicators help investors to evaluate how Teladoc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Teladoc shares will generate the highest return on investment. By understating and applying Teladoc stock market price indicators, traders can identify Teladoc position entry and exit signals to maximize returns.
| Price Series Summation | ||
| Price Series Division | ||
| Inverse Tangent Over Price Movement | ||
| Price Ceiling Movement | ||
| Aroon Oscillator | ||
| Balance Of Power | ||
| All Moving Average | ||
| MESA Adaptive Moving Average | ||
| Belt hold | ||
| Hanging Man |
Teladoc Return and Market Media
The median price of Teladoc for the period between Thu, Oct 30, 2025 and Wed, Jan 28, 2026 is 7.44 with a coefficient of variation of 9.34. The daily time series for the period is distributed with a sample standard deviation of 0.69, arithmetic mean of 7.38, and mean deviation of 0.51. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Hims Hers Plunges 15.6 percent in 3 Months Time to Hold the Stock or Sell | 11/18/2025 |
2 | Teladoc Health Surges 7.0 percent After TytoCare AI Diagnostics Integration Is Announced Has the Growth Narrative Shifted | 11/28/2025 |
3 | Disposition of 1189 shares by Kelly Bliss of Teladoc subject to Rule 16b-3 | 12/01/2025 |
4 | Disposition of 4209 shares by Rodrigues Fernando M. of Teladoc at 7.48 subject to Rule 16b-3 | 12/03/2025 |
5 | Acquisition by Divita Charles Iii of 160 shares of Teladoc subject to Rule 16b-3 | 12/10/2025 |
6 | Disposition of 1016 shares by Evans Jason Eric of Teladoc subject to Rule 16b-3 | 12/19/2025 |
7 | Why Teladoc Stock Is Up Today | 12/22/2025 |
8 | Acquisition by Catapano Joseph Ronald of 2083 shares of Teladoc subject to Rule 16b-3 | 01/02/2026 |
9 | Disposition of 758 shares by Catapano Joseph Ronald of Teladoc at 7.145 subject to Rule 16b-3 | 01/05/2026 |
10 | Why Teladoc Dipped More Than Broader Market Today | 01/07/2026 |
11 | Is Teladoc Losing Its Edge As BetterHelp Shrinks And Rivals Crowd Into Virtual Care | 01/08/2026 |
12 | Teladoc Health Launches Enhanced 247 Care Service | 01/12/2026 |
13 | Teladoc Health 24 7 Care Upgrade Prompts Fresh Look At Apparent Valuation Discount | 01/14/2026 |
14 | Teladoc Health Reaches New 12-Month Low Heres Why | 01/16/2026 |
15 | Teladoc Health shares tumble for seven consecutive sessions | 01/20/2026 |
16 | 2 Beaten-Down Stocks That Could Sink Even More in 2026 | 01/22/2026 |
17 | Teladoc Health Hits New 1-Year Low Should You Sell | 01/27/2026 |
About Teladoc Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Teladoc or other stocks. Alpha measures the amount that position in Teladoc has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 | 2025 (projected) | Days Sales Outstanding | 32.27 | 31.81 | 36.58 | PTB Ratio | 1.5 | 1.04 | 1.2 |
Teladoc Upcoming Company Events
As portrayed in its financial statements, the presentation of Teladoc's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Teladoc's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Teladoc's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Teladoc. Please utilize our Beneish M Score to check the likelihood of Teladoc's management manipulating its earnings.
| 28th of February 2024 Upcoming Quarterly Report | View | |
| 24th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Teladoc
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Teladoc Backtesting, Teladoc Valuation, Teladoc Correlation, Teladoc Hype Analysis, Teladoc Volatility, Teladoc History and analyze Teladoc Performance. For information on how to trade Teladoc Stock refer to our How to Trade Teladoc Stock guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Teladoc technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.